You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
邁普醫學(301033.SZ):再次通過高新技術企業認定
格隆匯 03-10 17:26

格隆匯3月10日丨邁普醫學(301033.SZ)公佈,公司於近日收到廣東省科學技術廳、廣東省財政廳、國家税務總局廣東省税務局聯合頒發的《高新技術企業證書》,證書編號:GR202144000832,發證日期:2021年12月20日,有效期:三年。

該次是公司持有的原高新技術企業證書有效期滿後進行的重新認定,根據《高新技術企業認定管理辦法》《中華人民共和國企業所得税法》等相關規定,公司自該次通過高新技術企業認定起連續三年(2021年度至2023年度)繼續享受國家關於高新技術企業的相關税收優惠政策,即按照15%的税率繳納企業所得税。公司2021年度已按15%的税率預繳企業所得税,上述税收優惠政策將不影響公司2021年度經營業績。

公司再次通過高新技術企業認定,是對公司創新研發實力、技術研發水平及高新技術企業成果的充分肯定。對提升企業品牌形象、享受税收減免優惠政策、提高企業市場價值、提高企業資本價值等均具有積極影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account